Roche and GE Healthcare Launch NAVIFY Tumor Board 2.0 for Personalized Treatment Decision in Cancer Care

Shots:

• The NAVIFY Tumor Board 2.0 with medical imaging capabilities brings a personalized treatment in patients with cancer with its initial availability in the US & Canada
• The tumor board enables radiologists to upload their patient records to the same dashboard where the patient’s previous treatment details are stored, helping the clinicians to have a quick review of all relevant files and to choose the best treatment for each cancer patient
• The NAVIFY tumor board is a web-based cancer care team workflow tool, presenting data in a dashboard and standardizes processes to encourage collaboration on patient treatment decisions

Click here to read full press release/ article | Ref: Roche | Image: The Business Journals